Cizzle Biotechnology (LON:CIZ) Trading Down 11.1% – Here’s Why

Cizzle Biotechnology Holdings Plc (LON:CIZ)’s stock price was down 11.1% during mid-day trading on Tuesday . The stock traded as low as GBX 2 and last traded at GBX 2. Approximately 75,237 shares were traded during trading, a decline of 92% from the average daily volume of 947,546 shares. The stock had previously closed at GBX 2.25.

Cizzle Biotechnology Stock Performance

The company has a quick ratio of 4.66, a current ratio of 0.48 and a debt-to-equity ratio of -54.35. The business has a 50 day moving average price of GBX 1.68 and a 200 day moving average price of GBX 1.61. The stock has a market cap of £7.53 million, a P/E ratio of -5.94 and a beta of 0.51.

About Cizzle Biotechnology

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.